West Pharmaceutical Services, Inc [WST] stock is trading at $269.13, up 1.01%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The WST shares have gain 0.81% over the last week, with a monthly amount glided 2.56%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
West Pharmaceutical Services, Inc [NYSE: WST] stock has seen the most recent analyst activity on December 02, 2025, when Morgan Stanley initiated its Equal-Weight rating and assigned the stock a price target of $285. Previously, Rothschild & Co Redburn started tracking the stock with Buy rating on September 15, 2025, and set its price target to $311. On June 24, 2025, Barclays initiated with a Equal Weight rating and assigned a price target of $245 on the stock. Evercore ISI started tracking the stock assigning an Outperform rating and suggested a price target of $275 on March 18, 2025. Deutsche Bank upgraded its rating to a Buy but $250 remained the price target by the analyst firm on February 14, 2025. Citigroup started tracking with a Buy rating for this stock on January 08, 2025, and assigned it a price target of $400. In a note dated December 13, 2024, Wolfe Research initiated an Peer Perform rating.
West Pharmaceutical Services, Inc [WST] stock has fluctuated between $187.43 and $348.90 over the past year. Currently, Wall Street analysts expect the stock to reach $335.17 within the next 12 months. West Pharmaceutical Services, Inc [NYSE: WST] shares were valued at $269.13 at the most recent close of the market. An investor can expect a potential return of 24.54% based on the average WST price forecast.
Analyzing the WST fundamentals
West Pharmaceutical Services, Inc [NYSE:WST] reported sales of 3.02B for the trailing twelve months, which represents a growth of 7.69%. Gross Profit Margin for this corporation currently stands at 0.36% with Operating Profit Margin at 0.21%, Pretax Profit Margin comes in at 0.2%, and Net Profit Margin reading is 0.16%. To continue investigating profitability, this company’s Return on Assets is posted at 0.12, Equity is 0.17 and Total Capital is 0.18. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.1.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 264.18 points at the first support level, and at 259.23 for the second support level. However, for the 1st resistance point, the stock is sitting at 274.82, and for the 2nd resistance point, it is at 280.51.
Ratios To Look Out For
For context, West Pharmaceutical Services, Inc’s Current Ratio is 2.87. Also, the Quick Ratio is 2.18, while the Cash Ratio stands at 0.99. Considering the valuation of this stock, the price to sales ratio is 6.42, the price to book ratio is 6.34 and price to earnings (TTM) ratio is 39.86.
